-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Amneal Pharmaceuticals, Raises Price Target to $17

Benzinga·03/02/2026 13:44:47
Listen to the news
Truist Securities analyst Les Sulewski maintains Amneal Pharmaceuticals (NASDAQ:AMRX) with a Buy and raises the price target from $15 to $17.